Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

Febbo PG, Ladanyi M, Aldape KD, De Marzo AM, Hammond ME, Hayes DF, Iafrate AJ, Kelley RK, Marcucci G, Ogino S, Pao W, Sgroi DC, Birkeland ML.

J Natl Compr Canc Netw. 2011 Nov;9 Suppl 5:S1-32; quiz S33.

PMID:
22138009
[PubMed - indexed for MEDLINE]
2.

NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement.

Engstrom PF, Bloom MG, Demetri GD, Febbo PG, Goeckeler W, Ladanyi M, Loy B, Murphy K, Nerenberg M, Papagni P, Robson M, Sweetman RW, Tunis S, Demartino J, Larsen JK; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Dec;9 Suppl 6:S1-16.

PMID:
22203777
[PubMed - indexed for MEDLINE]
3.

Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkers.

Berghoff AS, Stefanits H, Heinzl H, Preusser M.

Clin Neuropathol. 2012 Jul-Aug;31(4):206-9.

PMID:
22720693
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Recent advances in biomarkers for cancer diagnosis and treatment.

Manne U, Srivastava RG, Srivastava S.

Drug Discov Today. 2005 Jul 15;10(14):965-76. Review.

PMID:
16023055
[PubMed - indexed for MEDLINE]
5.

Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.

Mitra AP, Lin H, Cote RJ, Datar RH.

Natl Med J India. 2005 Nov-Dec;18(6):304-12. Review.

PMID:
16483031
[PubMed - indexed for MEDLINE]
6.

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.

Ong FS, Das K, Wang J, Vakil H, Kuo JZ, Blackwell WL, Lim SW, Goodarzi MO, Bernstein KE, Rotter JI, Grody WW.

Expert Rev Mol Diagn. 2012 Jul;12(6):593-602. doi: 10.1586/erm.12.59. Review.

PMID:
22845480
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.

Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ, Gown A, Hammond ME, Iglehart JD, Moench S, Pierce LJ, Ravdin P, Schnitt SJ, Wolff AC.

J Natl Compr Canc Netw. 2009 Sep;7 Suppl 6:S1-S21; quiz S22-3. Review.

PMID:
19755043
[PubMed - indexed for MEDLINE]
9.

Predictive pathology in routine diagnostics of solid tumors.

Lassmann S, Werner M.

Histol Histopathol. 2012 Mar;27(3):289-96. Review.

PMID:
22237706
[PubMed - indexed for MEDLINE]
10.

Antibody-based proteomics: fast-tracking molecular diagnostics in oncology.

Brennan DJ, O'Connor DP, Rexhepaj E, Ponten F, Gallagher WM.

Nat Rev Cancer. 2010 Sep;10(9):605-17. doi: 10.1038/nrc2902. Epub 2010 Aug 19. Review.

PMID:
20720569
[PubMed - indexed for MEDLINE]
11.

New cancer biomarkers deriving from NCI early detection research.

Verma M, Srivastava S.

Recent Results Cancer Res. 2003;163:72-84; discussion 264-6. Review.

PMID:
12903844
[PubMed - indexed for MEDLINE]
12.

New molecular assays for cancer diagnosis and targeted therapy.

Lea P, Ling M.

Curr Opin Mol Ther. 2008 Jun;10(3):251-9. Review.

PMID:
18535932
[PubMed - indexed for MEDLINE]
13.

Updates in cancer research: insights from the AACR 100th Annual Meeting.

Cho WC.

Expert Rev Mol Diagn. 2009 Jul;9(5):411-6. doi: 10.1586/erm.09.34.

PMID:
19580426
[PubMed - indexed for MEDLINE]
14.

Predictive biomarkers in advance of a companion drug: ahead of their time?

Kelley RK, Atreya C, Venook AP, Febbo PG.

J Natl Compr Canc Netw. 2012 Mar;10(3):303-9.

PMID:
22393192
[PubMed - indexed for MEDLINE]
15.

Commercialized multigene predictors of clinical outcome for breast cancer.

Ross JS, Hatzis C, Symmans WF, Pusztai L, Hortobágyi GN.

Oncologist. 2008 May;13(5):477-93. doi: 10.1634/theoncologist.2007-0248. Review. Erratum in: Oncologist. 2008 Aug;13(8). doi: 10.1634/theoncologist.2007-0248.

PMID:
18515733
[PubMed - indexed for MEDLINE]
Free Article
16.

Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.

Ross JS.

Adv Anat Pathol. 2009 Jul;16(4):204-15. doi: 10.1097/PAP.0b013e3181a9d4bf. Review.

PMID:
19546609
[PubMed - indexed for MEDLINE]
17.

DualChip microarray as a new tool in cancer research.

Gillet JP, de Longueville F, Remacle J.

Expert Rev Mol Diagn. 2006 May;6(3):295-306. Review.

PMID:
16706734
[PubMed - indexed for MEDLINE]
18.

NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.

Carlson RW, Brown E, Burstein HJ, Gradishar WJ, Hudis CA, Loprinzi C, Mamounas EP, Perez EA, Pritchard K, Ravdin P, Recht A, Somlo G, Theriault RL, Winer EP, Wolff AC; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2006 Mar;4 Suppl 1:S1-26. Review.

PMID:
16507275
[PubMed - indexed for MEDLINE]
19.

Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer.

Roukos DH, Murray S, Briasoulis E.

Cancer Biol Ther. 2007 Mar;6(3):308-12. Epub 2007 Mar 9. Review.

PMID:
17387266
[PubMed - indexed for MEDLINE]
Free Article
20.

Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groups.

Andre F, Nowak F, Arnedos M, Lacroix L, Viens P, Calvo F.

Clin Cancer Res. 2012 Mar 15;18(6):1555-60. doi: 10.1158/1078-0432.CCR-11-2201.

PMID:
22422408
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk